BridgeBio Pharma Inc. (BBIO) Tops Q3 EPS by 13c

BridgeBio Pharma Inc. (NASDAQ: BBIO) reported Q3 EPS of ($0.86), $0.13 better than the analyst estimate of ($0.99). Revenue for the quarter came in at $2.73 million versus the consensus estimate of $1.56 million.

For earnings history and earnings-related data on BridgeBio Pharma Inc. (BBIO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Trump: everybody is fully aware that Iran will agree to have major weapons inspections in order to ensure "nuclear honesty" long into future
• Incyte (INCY) PT Raised to $105 at Truist Securities